OpenEvidence Raises $200 Million for a ChatGPT for Medicine

Written by

in

The New York Times – Business:

The three-year-old artificial intelligence start-up has drawn investor attention, and money, as its use among doctors, nurses and others skyrockets.

This post first appeared in The New York Times – Business. Read the original article.